pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiska medel - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
fluconazole baxter 2 mg/ml infusionsvätska, lösning
baxter medical ab - flukonazol - infusionsvätska, lösning - 2 mg/ml - flukonazol 2 mg aktiv substans - flukonazol
glucos baxter viaflo 50 mg/ml infusionsvätska, lösning
baxter medical ab - glukosmonohydrat - infusionsvätska, lösning - 50 mg/ml - glukosmonohydrat 55 mg aktiv substans - kolhydrater
glucos baxter 25 mg/ml buffrad infusionsvätska, lösning
baxter medical ab - glukos (vattenfri); natriumacetattrihydrat; natriumklorid - infusionsvätska, lösning - glukos (vattenfri) 25 mg aktiv substans; natriumacetattrihydrat 3,4 mg aktiv substans; natriumklorid 2,63 mg aktiv substans - kolhydrater
glucos baxter 50 mg/ml buffrad infusionsvätska, lösning
baxter medical ab - glukos (vattenfri); natriumacetattrihydrat; natriumklorid - infusionsvätska, lösning - glukos (vattenfri) 50 mg aktiv substans; natriumklorid 2,63 mg aktiv substans; natriumacetattrihydrat 3,4 mg aktiv substans - kolhydrater
glucose-na-k baxter 50 mg/ml infusionsvätska, lösning
baxter medical ab - glukosmonohydrat; kaliumklorid; magnesiumkloridhexahydrat; natriumacetattrihydrat; natriumklorid - infusionsvätska, lösning - glukosmonohydrat 55 mg aktiv substans; natriumacetattrihydrat 3,13 mg aktiv substans; magnesiumkloridhexahydrat 0,3 mg aktiv substans; natriumklorid 1 mg aktiv substans; kaliumklorid 1,5 mg aktiv substans - elektrolyter och kolhydrater
dexmedetomidine baxter 100 mikrogram/ml koncentrat till infusionsvätska, lösning
baxter holding b.v. - dexmedetomidinhydroklorid - koncentrat till infusionsvätska, lösning - 100 mikrogram/ml - dexmedetomidinhydroklorid 118 mikrog aktiv substans
isofluran baxter inhalationsånga, vätska
baxter medical ab - isofluran - inhalationsånga, vätska - isofluran 1 ml aktiv substans - isofluran
natriumklorid baxter 9 mg/ml infusionsvätska, lösning
baxter medical ab - natriumklorid - infusionsvätska, lösning - 9 mg/ml - natriumklorid 9 mg aktiv substans - elektrolyter
natriumklorid baxter viaflo 9 mg/ml infusionsvätska, lösning
baxter medical ab - natriumklorid - infusionsvätska, lösning - 9 mg/ml - natriumklorid 9 mg aktiv substans - elektrolyter